$0.62
▼ -8.6% Today
as of Oct 23, 10:34 ET
Last 30 days
Recent Press Releases & News
MIRA Pharmaceuticals Reports MIRA-55 Demonstrated Significant Pain Relief Comparable to Celebrex in Chronic Inflammatory Pain Study
Modera Launches AI-Powered Platform Mira to Support Tailored Financial Advice for Clients
MIRA Pharmaceuticals Advances Ketamir-2 to Phase 2a in Chemotherapy-Induced Peripheral Neuropathy (CIPN) Following FDA Review
MIRA earnings at a glance
Over its last 2 reports the stock rose the next day 2 times and fell 0, moving ±6.6% on average; after the most recent report on May 14, 2026 it moved +0.4%. MIRA beat the consensus EPS estimate in 2 of its last 2 reported quarters. The share price of $0.62 sits near its 52-week low.
Overview
52-week range
$0.60
$1.79
2% of range
Avg surprise (last 2)
+22.4%
Avg reaction (last 2)
+6.6%
100% positive
Earnings trends
EPS — actual vs estimate
Actual Estimate
Revenue vs Net Income
Revenue Net income
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Tue Jun 30, 2026 | Jun 2026 | $-0.03 | — | — | — | — | financials |
| Thu May 14, 2026 | Mar/2026 | $-0.03 | — | — | +72.7% | +0.4% | earnings |
| Thu Nov 13, 2025 | Sep/2025 | $-1.18 | — | — | — | — | earnings |
| Thu Aug 14, 2025 | Jun/2025 | $-0.09 | $-0.11 | +18.2% | — | — | earnings |
| Wed May 14, 2025 | Mar/2025 | $-0.11 | $-0.15 | +26.7% | — | +12.7% | earnings |
| Mon Sep 30, 2024 | Sep 2024 | $-0.14 | — | — | — | — | financials |
| Sun Jun 30, 2024 | Jun 2024 | $-0.11 | — | — | — | — | financials |
| Sun Mar 31, 2024 | Mar 2024 | $-0.15 | — | — | — | — | financials |
| Sat Sep 30, 2023 | Sep 2023 | $-0.26 | — | — | — | — | financials |
| Fri Jun 30, 2023 | Jun 2023 | $-0.10 | — | — | — | — | financials |
| Fri Mar 31, 2023 | Mar 2023 | $-0.10 | — | — | — | — | financials |
Financials
Income statement (quarterly)
| Metric | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — |
| Cost of revenue | — | — | — | — | — | — | — | — |
| Gross profit | — | — | — | — | — | — | — | — |
| Operating income | — | — | — | — | — | — | — | — |
| Net income | $-1M | $-1M | — | $-1M | $-2M | $-2M | — | $-2M |
| EPS (diluted) | $-0.03 | $-0.03 | — | $-1.18 | $-0.09 | $-0.11 | — | $-0.14 |
Balance sheet (quarterly)
| Metric | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $4M | $5M | $6M | $3M | $730,475 | $1M | $3M | $4M |
| Inventory | — | — | — | — | — | — | — | — |
| Total current assets | $8M | $9M | $11M | $8M | $832,879 | $1M | $3M | $4M |
| Total assets | $8M | $9M | $11M | $8M | $868,318 | $1M | $3M | $4M |
| Long-term debt | — | — | — | — | — | — | — | — |
| Total liabilities | $40,823 | $114,761 | $702,068 | $83,926 | $298,459 | $106,173 | $723,349 | $692,833 |
| Total equity | $8M | $9M | $10M | $8M | $569,859 | $1M | $2M | $4M |
Implied volatility — last 90 days
No IV snapshots yet for MIRA.
IV is captured twice daily (9:15 AM & 4:30 PM ET) for tickers with upcoming earnings. Comes online automatically once the next options refresh runs.
Sector peers
MIRA earnings FAQ
How does MIRA stock usually react to earnings?
Across the last 2 reports the average next-day move was ±6.6%, up 2 times and down 0 times.